Videos

Dr. Ticiana Leal from Emory University's Winship Cancer Institute and Dr. Wade Iams from Tennessee Oncology introduce their discussion on Lambert-Eaton myasthenic syndrome (LEMS) in patients with small-cell lung cancer (SCLC). This paraneoplastic syndrome affects approximately 3% of patients with SCLC but remains undiagnosed in up to 90% of cases, representing a significant clinical challenge where symptoms often overlap with expected disease progression or treatment-related adverse effects in busy oncology settings.

3 experts are featured in this series

In this segment on advanced renal cell carcinoma, Dr. McGregor highlights the challenges of managing comorbidities in community practice and how these factors influence treatment selection. Dr. Wulff and Dr. Geynisman discuss practical strategies for adapting guideline-based therapies in patients with cardiovascular disease, pulmonary conditions, and baseline anemia.